Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity

World Journal of Gastroenterology

Volumn 12, Issue 43, 2006, Pages 7042-7046

  Sun, Bo ^a   Li, Zhao Shen ^a   Tu, Zhen Xing ^a   Xu, Guo Ming ^a   Du, Yi Qi ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DNA vaccine; H pylori; Neutrophil activating protein

Indexed keywords

BACTERIUM ANTIBODY; DNA VACCINE; GENOMIC DNA; HELICOBACTER PYLORI VACCINE; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; CELL STRAIN COS7; CONTROLLED STUDY; DNA EXTRACTION; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ENGINEERING; GENETIC TRANSFECTION; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECOMBINANT PLASMID; SALMONELLA TYPHIMURIUM; SEQUENCE HOMOLOGY; VACCINE PRODUCTION; WESTERN BLOTTING;

EID: 33751547811     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i43.7042     Document Type: Article

References (22)

1. Kirsner JB. The origin of 20th century discoveries transforming clinical gastroenterology. Am J Gastroenterol 1998; 93: 862-871
2. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321-333
3. Sanders MK, Peura DA. Helicobacter pylori-associated diseases. Curr Gastroenterol Rep 2002; 4: 448-454
4. Olbe L, Fandriks L, Hamlet A, Svennerholm AM, Thoreson AC. Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease: an overview. World J Gastroenterol 2000; 6: 619-623
5. Sun B, Yang H, Tu ZX, Li ZS. Helicobacter pylori and gastric cancer. Acad J Sec Mil Med Univ 2003; 24: 1356-1358
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 13; 345: 784-789
7. Jiang Z, Huang AL, Tao XH, Wang PL. Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori. World J Gastroenterol 2003; 9: 1756-1761
8. Liu MA. DNA vaccines: a review. J Intern Med 2003; 253: 402-410
9. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001; 19: 523-563
10. Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, Tonello F, Kelleher D, Rappuoli R, Montecucco C, Rossi F. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 2000; 191: 1467-1476
11. Srivastava IK, Liu MA. Gene vaccines. Ann Intern Med 2003; 138: 550-559
12. Gentschev I, Dietrich G, Spreng S, Kolb-Maurer A, Brinkmann V, Grode L, Hess J, Kaufmann SH, Goebel W. Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 2001; 19: 2621-2628
13. Dietrich G, Kolb-Maurer A, Spreng S, Schartl M, Goebel W, Gentschev I. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines. Vaccine 2001; 19: 2506-2512
14. Todoroki I, Joh T, Watanabe K, Miyashita M, Seno K, Nomura T, Ohara H, Yokoyama Y, Tochikubo K, Itoh M. Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice. Biochem Biophys Res Commun 2000; 277: 159-163
15. Miyashita M, Joh T, Watanabe K, Todoroki I, Seno K, Ohara H, Nomura T, Miyata M, Kasugai K, Tochikubo K, Itoh M, Nitta M. Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase. Vaccine 2002; 20: 2336-2342
16. Namavar F, Sparrius M, Veerman EC, Appelmelk BJ, Vandenbroucke-Grauls CM. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect Immun 1998; 66: 444-447
17. Teneberg S, Miller-Podraza H, Lampert HC, Evans DJ Jr, Evans DG, Danielsson D, Karlsson KA. Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J Biol Chem 1997; 272: 19067-19071
18. Evans DJ Jr, Evans DG, Takemura T, Nakano H, Lampert HC, Graham DY, Granger DN, Kvietys PR. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun 1995; 63: 2213-2220
19. Nishioka H, Baesso I, Semenzato G, Trentin L, Rappuoli R, Del Giudice G, Montecucco C. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils. Eur J Immunol 2003; 33: 840-849
20. Dundon WG, Nishioka H, Polenghi A, Papinutto E, Zanotti G, Montemurro P, Del GG, Rappuoli R, Montecucco C. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol 2002; 291: 545-550
21. Montemurro P, Barbuti G, Dundon WG, Del Giudice G, Rappuoli R, Colucci M, De Rinaldis P, Montecucco C, Semeraro N, Papini E. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis 2001; 183: 1055-1062
22. Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G, Rappuoli R, Montecucco C. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 2002; 32: 671-676